98%
921
2 minutes
20
Background/purpose: The significance of Dense Fine Speckled (DFS) pattern Anti-nuclear antibodies (ANA) by indirect mmunofluorescence (IIF) is unclear in the existing research. We aimed to investigate associations between positive ANA with DFS pattern and multiple autoimmune and rheumatic conditions.
Methods: This retrospective study analyzed datasets from patients tested for ANA between August 2017 and August 2019. Comparisons were made between diagnostic categories and diseases for patients with negative ANA, positive ANA (any pattern), and positive ANA with DFS pattern. Relative risk (RR) was calculated for diagnostic categories and individual diseases.
Results: Of 13,845 ANA results, 65.8% were negative and 34.2% were positive, including 4.6% with DFS pattern. Among ANA positive DFS pattern patients, 10.6% had inflammatory arthritis, 20.6% had fibromyalgia/chronic pain syndrome/chronic fatigue, 13.3% had SARD and only 2.2% had atopic disorder. Comparing ANA positive other patterns and DFS pattern, specific diagnoses like seropositive RA, SLE, SSc, and UCTD were lower among ANA positive DFS pattern. Similarly, diagnoses of Raynaud's with SSc or UCTD were lower in DFS pattern patients compared to ANA positive with other patterns. The rate of other diagnoses including seronegative RA, IIM, SS, autoimmune thyroid disorder, and autoimmune hepatitis did not differ between other patterns and DFS pattern.
Conclusion: The presence of DFS pattern cannot indiscriminately exclude the presence of SARD or rheumatic disease, as diagnoses including seronegative RA, IIM, SS, autoimmune thyroid disorder, or autoimmune hepatitis did not differ among ANA positive with other patterns and DFS pattern.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12341086 | PMC |
http://dx.doi.org/10.46439/rheumatology.5.027 | DOI Listing |
Int J Radiat Oncol Biol Phys
September 2025
Department of Oncology and Radiotherapy, Medical University of Gdańsk, Smoluchowskiego 17 str., 80-215, Gdańsk, Poland.
Background: Stereotactic Ablative Radiotherapy (SABR) for early-stage non-small cell lung cancer (NSCLC) can stimulate an immune response against cancer. We evaluated changes in peripheral lymphocyte subpopulations and cytokines levels after SABR in patients with early-stage NSCLC. We examined how these changes relate to overall survival (OS) and disease-free survival (DFS).
View Article and Find Full Text PDFLung Cancer
September 2025
Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, PR China. Electronic address:
Objective: We aimed to investigate the prognostic significance of ROS1 fusion in surgically resected lung adenocarcinoma (LUAD).
Materials And Methods: Consecutive patients who underwent complete resection and ROS1 testing between 2015 and 2020 were included. Propensity score matching (1:2) was applied to balance baseline characteristics.
J Inflamm Res
August 2025
Department of Comprehensive Surgery, Wenzhou Central Hospital, Wenzhou, People's Republic of China.
Purpose: Hepatocellular carcinoma (HCC) recurrence remains a significant burden on global healthcare. Hepatic ischemia-reperfusion injury (HIRI) is a common complication in liver surgery and may be a contributing factor to HCC recurrence. Nevertheless, the potential mechanism underlying HIRI-induced HCC recurrence has not been fully elucidated.
View Article and Find Full Text PDFWorld J Surg Oncol
September 2025
Department of Breast Surgery, The Affiliated Huizhou Hospital, Guangzhou Medical University, No.1 Xuebei Road, Huizhou, Guangdong, 516000, China.
Introduction: HER2-negative breast cancers can be further subclassified into HER2-low and HER2-zero subtypes. The DESTINY-Breast04 trial has established HER2-low as a research hotspot, with recent studies indicating superior survival rates in HER2-low patients than HER2-zero patients. The impact of heterogeneous hormone receptor (HR) expression patterns on HER2-negative breast cancer has not been comprehensively investigated.
View Article and Find Full Text PDFScand J Urol
September 2025
Department of Urology, Skåne University Hospital, Malmö, Sweden; Institution of Translational Medicine, Lund University, Malmö, Sweden.
Background: The role of cystectomy in synchronous oligometastatic bladder cancer is unclear.
Objective: To describe a population-based consecutive cohort with primary oligometastatic bladder cancer (M1a or M1b) treated with curative intent. Methods: Twenty consecutive patients with primary stage M1a or M1b bladder cancer subjected to induction chemotherapy and radical cystectomy 2013-2024 in the Southern healthcare region were identified in the Swedish National Register for Urinary Bladder Cancer.